Clinical Trials Browser

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00895739 2013-08-12

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Phase 2 Unknown

50 enrolled

Classical hematology

Anemia, Aplastic, Neoplasms

NCT00737685 2012-03-26

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

Phase 2 Unknown

30 enrolled

Classical hematologyLymphoid

Anemia, Aplastic, Lymphoma, Follicular

NCT00315419 2010-04-21

Identifying Characteristics of Bone Marrow Failure Syndromes

Unknown

450 enrolled

Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoid, Myelodysplastic Syndromes, Purpura, Thrombocytopenic, Red-Cell Aplasia, Pure, Leukemia, Large Granular Lymphocytic

Clinical Trials

ToTem

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells

B-cell therapy

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

Identifying Characteristics of Bone Marrow Failure Syndromes